The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.50
Bid: 137.90
Ask: 138.00
Change: 1.45 (1.07%)
Spread: 0.10 (0.073%)
Open: 136.35
High: 138.55
Low: 136.35
Prev. Close: 136.05
CNA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

14 Apr 2020 07:00

RNS Number : 4694J
Centrica PLC
14 April 2020
 

14 April 2020

Centrica plc

("the Company")

 

Group Chief Executive appointment

 

Centrica plc is pleased to announce the appointment of Chris O'Shea as Group Chief Executive on a permanent basis with immediate effect.

Scott Wheway, Centrica Chairman, said:

"In the last few weeks since my appointment I have completed a review of both the internal and external candidates for this role and have come to the conclusion that Chris is comprehensively the best candidate for Centrica. I'm delighted to appoint him to the role on a permanent basis.

"The Board is confident that he is the right leader to navigate Centrica through and beyond the present Covid-19 crisis focusing on the welfare of our colleagues and customers, the financial resilience of the company and the agility to move quickly when we emerge from these unprecedented circumstances."

Chris O'Shea said:

"It is a huge honour to be appointed to lead Centrica. The company has a long history of serving customers, strong market positions and over recent years has built the capabilities to help our customers transition to a low carbon future. I'm very proud of how the Centrica team is looking after our customers and our colleagues through the Covid-19 crisis.

"Beyond this present emergency our focus will be on creating value for all of our stakeholders through delivering growth in our customer facing businesses, the structural simplification of the Group, and building on the undoubted strengths and capabilities we have in our people and our businesses today."

Notes to Editors

Chris O'Shea was appointed to the Centrica Board as Group Chief Financial Officer on 1 November 2018 and became interim CEO with effect from 17 March 2020.

Chris O'Shea's remuneration package will consist of a basic salary and variable incentive arrangements which are in line with Centrica's current remuneration policy and practice. The key changes to his current arrangements are a base salary of £775,000 and a reduction from 15% to 10% pension contribution.

In recognition of the current crisis, Chris has already taken a voluntary reduction in salary of £100,000. This reduction will continue until the company resumes normal operations.

The company has commenced a search for a new Chief Financial Officer, and an announcement will be made in due course.

The information communicated in this announcement is inside information.

 

ENDS

 

Enquiries:

 

Investors/analysts 01753 494900 ir@centrica.com

 

Media 01784 843000 media@centrica.com

 

 

Centrica plc is listed on the London Stock Exchange (CNA)Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654Legal Entity Identifier number: E26EDV109X6EEPBKVH76ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAIJMMTMTMBTFM
Date   Source Headline
10th May 20246:00 pmRNSTransaction in Own Shares
10th May 20249:07 amRNSCentrica announces new issue and tender offer
9th May 20246:00 pmRNSTransaction in Own Shares
8th May 20246:00 pmRNSTransaction in Own Shares
7th May 20246:00 pmRNSTransaction in Own Shares
3rd May 20246:00 pmRNSTransaction in Own Shares
2nd May 20246:00 pmRNSTransaction in Own Shares
1st May 20246:00 pmRNSTransaction in Own Shares
1st May 20245:00 pmRNSBlock listing Interim Review
1st May 20244:30 pmRNSTotal Voting Rights
30th Apr 20246:00 pmRNSTransaction in Own Shares
29th Apr 20246:00 pmRNSTransaction in Own Shares
26th Apr 20246:00 pmRNSTransaction in Own Shares
25th Apr 20246:00 pmRNSTransaction in Own Shares
25th Apr 20245:30 pmRNSDirector/PDMR Shareholding
25th Apr 20242:00 pmRNSNotice of AGM
24th Apr 20246:00 pmRNSTransaction in Own Shares
23rd Apr 20246:00 pmRNSTransaction in Own Shares
22nd Apr 20246:00 pmRNSTransaction in Own Shares
19th Apr 20246:00 pmRNSTransaction in Own Shares
18th Apr 20246:00 pmRNSTransaction in Own Shares
17th Apr 20246:00 pmRNSTransaction in Own Shares
16th Apr 20246:00 pmRNSTransaction in Own Shares
15th Apr 20246:25 pmRNSTransaction in Own Shares
12th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20241:30 pmRNSDirector/PDMR Shareholding
10th Apr 20246:00 pmRNSTransaction in Own Shares
9th Apr 20246:00 pmRNSTransaction in Own Shares
8th Apr 20246:00 pmRNSTransaction in Own Shares
8th Apr 20245:30 pmRNSDirector Declaration
4th Apr 20246:00 pmRNSTransaction in Own Shares
3rd Apr 20246:00 pmRNSTotal Voting Rights - Replacement
3rd Apr 20246:00 pmRNSTransaction in Own Shares
2nd Apr 20246:25 pmRNSTransaction in Own Shares
2nd Apr 20241:00 pmRNSTotal Voting Rights
28th Mar 20246:00 pmRNSTransaction in Own Shares
27th Mar 20246:25 pmRNSTransaction in Own Shares
26th Mar 20246:30 pmRNSTransfer of Treasury Shares
26th Mar 20246:00 pmRNSTransaction in Own Shares
26th Mar 20243:25 pmRNSDirector/PDMR Shareholding
26th Mar 20243:25 pmRNSDirector/PDMR Shareholding
26th Mar 20243:20 pmRNSAnnual Financial Report 2023
25th Mar 20246:00 pmRNSTransaction in Own Shares
25th Mar 20245:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20246:00 pmRNSTransaction in Own Shares
21st Mar 20246:00 pmRNSTransaction in Own Shares
20th Mar 20246:00 pmRNSTransaction in Own Shares
19th Mar 20246:00 pmRNSTransaction in Own Shares
18th Mar 20246:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.